Animal behavioral models for testing antianxiety agents

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 3, 1996, Pages 219-230

  Kulkarni, S K ^a   Ready, Doodipala Samba ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR;

ANIMAL MODEL; ANXIETY; BEHAVIOR; DISCRIMINATIVE STIMULUS; LABORATORY TEST; NONHUMAN; REVIEW;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DRUG EVALUATION, PRECLINICAL;

EID: 0030048392     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Bignami, G. Pharmacology and anxiety inadequacies of current experimental approaches and working models. Pharmacol Biochem Behav 1988, 29: 711-74.
2. Clody, D.E., Lippa, A.S., Beer, B. Preclinical procedures as predictors of anxiety in man. In. Pharmacology of Benzodiazepines. E. Usdin et al. (Eds.). MacMillan Press: London 1982, 341-453.
3. Costa, E., Guidotti, A., Mao, C., Suria, A. New concepts in the mechanism of action of benzodiazepines. Life Sci 1975, 17: 167-86.
4. Kulkarni, S.K., Reddy, D.S. Neurosteroids: A new class of neuromodulators. Drugs Today/Med Actual 1995, 31: 433-55
5. Harris, R.A , Allan, A M. Functional coupling of γ-aminobutvric acid receptors to chloride channels in brain membranes. Science 1985, 228: 1108-10.
6. Morselli, P.L., Lloyd, K.G. Clinical pharmacology of GABA agonists. In: The GABA Receptors. S.J. Enna (Ed.) Humana Press: Clifton, NJ 1983, 305-36.
7. Kulkarni, S.K, Mehta, A.K. Benzodiazepine receptor antagonists and inverse agonists. Drugs Today/Med Actual 1985. 21: 145-53.
8. Tikku, M.K., Kulkarni, S.K. Molecular interactions of ethanol with GABAergic system and the potential of Ro 15-4513 as an ethanol antagonist. Pharmacol Biochem Behav 1988, 30: 501-10.
9. Kulkarni, S.K., Sharma, A.C. Benzodiazepines and cognition, learning and memory. Drugs Today/Med Actual 1990, 26:5 41-5.
10. Kulkarni, S.K. Steroids, stress and GABA-benzodiazepine receptor interaction. Drugs Today/Med Actual 1989, 25: 555-61.
11. Treit, D. Neurosci Biobehav Res 1985, 9: 203-22.
12. Green, S., Hodges. H, In: Benzodiazepine Models in Psychopharmacology. P. Willner (Ed.). Cambridge University Press: Cambridge 1990, 21-49.
13. Lal, H., Emmett-Oglesby, M.W. Behavioural analogues of anxiety: Animal models. Neuropharmacology 1983, 22. 1423-41.
14. Freedman, A K., Kaplan, H.I., Sadock, B.J. Modern Synopsis of Psychiatry, II. Williams & Wilkins: Baltimore 1976, 611-2.
15. Schuster, C.R., Brady, Jr. The discriminative control of a food-reinforced operant by interoceptive stimulation. In: Stimulus Properties of Drugs. T. Thompson, R. Pickens (Eds.). Appleton-Century-Crofts: New York 1971, 133-48.
16. Lal, H. Interoceptive stimuli as tools of drug development. Drug Dev Indust Pharmacol 1979, 5: 133-49.
17. Lal, H. Drug-induced discriminable stimuli: Past research and future perspective. In: Discriminative Stimulus Properties of Drugs. H. Lal (Ed.). Plenum Press: New York 1977, 207-32.
18. Calpaert, F., Rosecrans, J. (Eds.). Stimulus Properties of Drugs: Ten Years of Progress. Elsevier/ North-Holland: Amsterdam 1978.
19. Weissman, A. Drugs as discriminative stimuli. Adv Behav Biol 1977, 22: 1-3.
20. Lal, H., Shearman, G.T. Attenuation of chemically-induced anxiogenic stimuli as a novel method for evaluating anxiolytic drugs: A comparison of clobazepam with other benzodiazepines. Drug Dev Res 1982, (Suppl. 1): 27-134.
21. Redmond, D.E. Jr., Haung, Y.H., Snyder, D.R., Mars, J.W. Behavioural effects of stimulation of the locus coeruleus in the stump-tailed monkey. Brain Res 1976, 116: 502-10.
22. Bertrand, M. The Behavioural Repertoire of the Stump-Tailed Macaque. Karger: New York 1969.
23. Redmond, D.E. Jr. Clonidine and the primate locus coeruleus: Evidence suggesting anxiolytic and antiwithdrawal effects. Prog Clin Biol Res 1981, 71: 147-63.
24. Segal, D S., Janowsky, D.S. Psychastimulani-induced behavioural effects: Possible models of schizophrenia. In: Psychopharmacology: A Generation of Progress. M. A. Lipton. A. DiMascio, R.F. Killam (Eds.). Raven Press: New York 1978, 1113-23.
25. Siegel, R.K. Cocaine: Recreational use and intoxication. In: Cocaine, R.C., Petersen, R.C. Stilman (Eds.). US Govt Printing Office: Washington, DC 1977, 119-29.
26. Floodmark, S., Peterson, L., Sternbers, K., Activation with Megimide (β,β-methylethyiglutarimide) in electroencephalographic investigation of epileptic conditions. Electroenceph Clin Neurophysiol 1957, 9: 371-2.
27. Franz, D. Central nervous system stimulants. In: The Pharmacological Basis of Therapeutics. L. Goodman. A. Oilman (Eds.). MacMillan: New York 1975, 360-1.
28. Baldwin, H.J., File, S.E. Caffeine-induced anxiogenesis. The role of adenosine. benzodiazepine and noradrenergic receptors. Pharmacol Bioehem Behav 1989, 32: 181-6.
29. Charney, D.S., Heninger. G.R., Redmond, D.E. Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidme. Life Sci 1983, 33: 19-29.
30. Johnston, A.L., File, S.E. Yohimbine's anxiogenic action: Evidence for noradrenergic and dopaminergic sites. Pharmacol Bioehem Behav 1989, 32: 151-6.
31. File, S.E., Lister, R.G., Nun, D.J. The anxiogenic actions of benzodiazepine antagonists. Neuropharmacology 1982, 21: 1033-7.
32. Shanbhogue, R., Hrishikeshavan, H.J., Devi, K., Munonyedi, S. Behavioural neurobiology of inverse agonist FC-7I42 induced anxiety syndrome in rats. Prog Neuro-Psychopharmacol Biol Psychiat 1990, 14: 249-60.
33. Green, S. Benzodiazepines. putative anxiolytics and animal models of anxiety. Trends Neurosci 1991, 14: 101-4.
34. Geller, I., Seifter, J. The effects of meprobamate, d-amphetamine and promazine on experimentally-induced conflict in the rat. Psychopharmacologia 1960, 1. 482-92.
35. Prado de Carvalho, L., Greksch, G., Chapouthier, G., Rossier, J. Anxiogenic and non-anxiogenic benzodiazepine antagonist. Nature 1983, 301: 64-6
36. Vogel, J.R., Beer, B., Clody., D.E.A simple and reliable conflict procedure for testing amianxiety agents. Pychopharmacologia 1971, 21: 1-7.
37. Corda, M.G., Blaker, W.D., Mendelson, W B . Guidotti, A., Costa, E. Beta-carbolines enhance shock-induced suppression of drinking in rats Proc Natl Acad Sci USA 1983, 80: 2072-6.
38. Beer, B., Ghasin, M., Clody, D., Vogel, J.R., Horovitz, Z.P. Cyclic adenosine monophosphate phosphodiesterase in brain: Effect on anxiety. Science 1972, 176: 428-30.
39. Rawlins, J.N.P., Feldon, J., Salmon, P. Gray, J.A., Garrud, P. The effects of chlorodiazepoxide HCl administration upon punishment and conditioned suppression in the rat Psychopharmacology 1980, 70: 317-22.
40. Brown, J.S., Kalish, H.I., Farber. I E. Conditioned fear as measured by magnitude of startle response to an auditory stimulus. J Exp Psychol 1951, 41: 317-28.
41. File, S.E., Hyde, J.R.G. A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants. Pharmacol Biochem Behav 1979, 11: 65-8.
42. File, S.E. The use of social interaction as a method for detecting anxioiy tic activity of chlordiazepoxide-like drugs. Neurosci Methods 1980, 2: 219-48.
43. Haug, M., Simler, S., Ciesielski, P., Mandel, P., Moutier, R. Influence of castration and brain GABA levels in three strains of mice on aggression towards lactating intruders. Physiol Behav 1984, 32: 767-70.
44. Aley, K.O., Kulkarni, S.K. GABAergic agents and clonidine attenuate fool shock-induced aggression in mice. Meth Find Exp Clin Pharmacol 1989, 11: 541-5.
45. Kulkarni, S.K , Dandiya, P.C. Effects of antidepressant agents on open field behaviour in rats. Psychopharmacologia (Berlin) 1973, 33: 333-8.
46. Dandiya, P.C., Kulkarni, S. K. A study of the open field behaviour as a single parameter. Ind J Pharmacol 1975, 7: 1-4.
47. Kulkarni, S.K., Open field test: Its status in psychopharmacology. Ind J Pharmacol 1977, 9: 241-6.
48. Kulkarni, S.K., Dandiya, P.C. A preliminary report on the action of imipramine and antiparkinsontan agents on the open field behaviour of rats. Jpn J Pharmacol 1974, 24: 809-10.
49. Kulkarni, S.K., Dandiya, P.C., Jain, K.M. A comparative study of the influence of 6-hydroxydopamine, α-methyltyrosine and 5.6-dihydroxytryptamine, p-chlorophenylalanine on the open field behaviour of rats. Ind J Physiol Pharmacol 1974. 15: 324-9.
50. Pelow, P., File, S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test for anxiety in the rat. Pharmacol Biochem Behav 1986, 24: 525-9.
51. Kulkarni, S.K., Sharma, A.C., Verma, A. Strain differences and bidirectional activity of benzodiazepine ligands in rodents subjected to elevated plus-maze. Ann Natl Acad Med Sci (India) 1991, 27: 61-8.
52. Kulkarni, S.K., Sharma, A.C. Elevated plus-maze: A novel psychobehavioural tool to measure anxiety in rodents. Meth Find Exp Clin Pharmacol 1991, 13: 573-7.
53. Lister, R.G. The use of a plus -maze to measure anxiety in the mouse. Psychopharmacology 1987, 92: 180-5.
54. Sharma, A.C., Kulkarni, S.K MK-801 produces antianxiety effect in elevated plus-maze in mice. Drug Dev Res 1991, 22: 251-8.
55. Montgomery, K.C. The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 1958, 48: 254-60.
56. Handley, S.L., Mithani, S. Effects of a-adrenoceptor agonists and antagonists on maze-exploration model of "fear" motivated behaviour. Naunyn-Schmied Arch Pharmacol 1984, 327: 1-5.
57. Pellow, S., Chopin, P., File, S.E., Briley, M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14: 149-67.
58. Kulkarni, S.K. (Ed.). Handbook of Experimental Pharmacology, 2nd Ed. Vallabha Prakashan: New Delhi 1993.
59. Itoh, J., Nabeshima, T. Kameyama, T. Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of noolropics. scopolamine and electroconvulsive shock. Psychopharmacology 1990, 101: 27-33.
60. Christmas, A.J., Maxwell, D.R. A comparison of the effects of some behaviour in mice and rats. Neuropharmacology 1970, 9: 17-29.
61. Crawley, J.N., Goodwin, F.K. Preliminary report of a simple animal behaviour model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980, 13: 167-70.
62. Costall, B., Jones, B.J., Kelley, M.E., Naylor, R.J., Tomkins, D.M. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacol Biochem Behav 1989, 32: 771-85.
63. Toubas, P.L., Abla, R.A., Cao. W., Logen, L.G., Seale, T.W. Latency to enter a mirrored chamber: A novel behavioural assay for anxiolytic agents. Pharmacol Biochem Behav 1990, 35: 121-6.
64. Gallup, G.G. Jr. Mirror-image stimulation. Psychol Bull 1968, 70: 782-93.
65. Nolan, N.A., Parkes, M.W. The effect of benzodiazepines on the behaviour of mice on a hole-board. Psychopharmacologia 1973, 29: 277-88.
66. Soubrie, P., Kulkarni, S.K., Simon, P., Boissier, J.R. Effects of antianxiety drugs on the food intake in trained and untrained rats and mice. Psychopharmacoloaia 1975, 45: 203-10.
67. Annau, Z., Kamin, L.J The conditioned emotional response as a fonction of the intensity of the US. J. Comp Physiol Psychol 1961, 54: 428-432.
68. Grossen, N.E., Belles, R.C. Effects of a classical conditioned "fear signal" and "safety signal" on nondiscriminated avoidance behaviour. Psychoneurol Sci 1968, 11: 321-2.
69. Quintero, S., Henney, S., Lawson, P., Mellanby, J., Gray, J.A. The effects of compounds related to gamma-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: Punished bar pressing. Psychopharmacology 1985, 85: 244-51.
70. Miller, R.E., Murphy, J. V., Mirsky, I.A. The effect of chlorpromazine on fear-motivated behaviour rats. J Pharmacol Exp Ther 1957 120: 379-87.
71. Dorow, R., Horowski, R., Paschelkeg, A., Mand-Braestrup, C. Severe anxiety induced by FG-7I42. a β-carboline ligand for BDZ receptors. Lancet 1983, ii: 98-9.
72. Morpurgo, C. Aggressive behaviour induced by large doses of 2-(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride in mice Eur J Pharmacol 1968, 3: 374-7.